Revvity (RVTY) Stock Analysis

November 11, 2026

This is a peer-relative look at Revvity (RVTY): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for Revvity (RVTY)
Profile Item	RVTY
Name	Revvity Inc.
Country/Region	United States
GICS Sector	Health Care
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
GICS Industry	Life Sciences Tools & Services
GICS Sub-Industry	Life Sciences Tools & Services
Market Capitalization	17.31 billion USD
Currency	USD
Exchange	NYSE
Listing Date	February 21, 1973
Security Type	Common Stock

Price Performance

Cumulative Growth

RVTY

GSPC

Revvity (RVTY) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Revvity (RVTY) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Revvity (RVTY) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Revvity (RVTY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: RVTY	Industry group median
Total Return (1Y)	76.75%	24.62%
Total Return (3Y, Annualized)	24.22%	20.37%
Total Return (5Y, Annualized)	-1.48%	-4.02%

Risk Profile

Drawdown History

RVTY

GSPC

Revvity (RVTY) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Revvity (RVTY) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Revvity (RVTY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: RVTY	Industry group median
Volatility (1Y, Annualized)	40.22%	66.36%
Beta (5Y)	1.07	0.93
Max Drawdown (5Y)	-59.01%	-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. RVTY is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Revvity (RVTY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: RVTY	Industry group median
Sharpe Ratio (1Y)	1.80	0.36
Sortino Ratio (1Y)	2.90	0.58

Profitability

ROE (TTM)

Revvity (RVTY) posts ROE of 3.45%, roughly around the peer group’s normal range. Shareholders’ equity is producing a return that looks broadly typical for the industry.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.45%

Group distribution

Max: 109.18%
Q3: 6.23%
RVTY: 3.45%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

Largest peers

LLY: 86.02%
NVS: 24.33%
AZN: 22.57%
JNJ: 20.02%
MRK: 5.06%
RVTY: 3.45%
ABBV: --

Where Revvity (RVTY) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Revvity (RVTY) keeps 8.61% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.61%

Group distribution

Max: 18.05%
RVTY: 8.61%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

Largest peers

LLY: 31.90%
AZN: 17.68%
NVS: 17.49%
JNJ: 16.20%
ABBV: 15.67%
RVTY: 8.61%
MRK: 3.64%

Where Revvity (RVTY) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Revvity (RVTY) turns 17.06% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

17.06%

Group distribution

Max: 83.12%
RVTY: 17.06%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

Largest peers

LLY: 53.66%
ABBV: 39.59%
MRK: 35.22%
NVS: 34.27%
AZN: 29.57%
JNJ: 25.74%
RVTY: 17.06%

Where Revvity (RVTY) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Revvity (RVTY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: RVTY	Industry group median
ROE (TTM)	3.45%	-26.66%
ROA (TTM)	2.54%	-12.50%
Net Margin (TTM)	8.61%	0.00%
Operating Margin (TTM)	17.06%	0.00%
Gross Margin (TTM)	55.91%	37.87%

Growth

Revenue Growth

Revvity (RVTY) grew revenue 3.67%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.

Revvity (RVTY): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

Revvity (RVTY) grew earnings per share -5.91%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.

Revvity (RVTY): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

Revvity (RVTY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: RVTY	Industry group median
Revenue Growth (YoY)	3.67%	11.45%
Revenue Growth (3Y CAGR)	-4.82%	9.94%
EPS Growth (YoY)	-5.91%	4.28%
EPS Growth (3Y CAGR)	-23.26%	4.17%

Financial Strength

Current Ratio (MRQ)

Revvity (RVTY) has current ratio of 2.65, in the healthier middle range for its industry. The short-term asset cushion looks balanced relative to peers rather than stretched thin.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.65

Group distribution

Max: 25.13
Q3: 12.13
Median: 5.52
RVTY: 2.65
Q1: 2.47
Min: 0.10

Largest peers

RVTY: 2.65
LLY: 1.39
MRK: 1.35
JNJ: 1.02
AZN: 1.01
NVS: 0.88
ABBV: 0.87

Where Revvity (RVTY) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Revvity (RVTY) has debt-to-equity ratio of 0.38, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.38

Group distribution

Max: 1.42
Q3: 0.65
RVTY: 0.38
Median: 0.15
Q1: 0.02
Min: 0.00

Largest peers

NVS: 1.29
LLY: 1.23
MRK: 1.20
AZN: 0.66
JNJ: 0.55
RVTY: 0.38
ABBV: --

Where Revvity (RVTY) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Revvity (RVTY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: RVTY	Industry group median
Current Ratio (MRQ)	2.65	5.52
Debt / Equity (MRQ)	0.38	0.15
Net Debt / EBITDA	2.43	1.08

Dividends

Dividend Yield (TTM)

Revvity (RVTY) has dividend yield of 0.19%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.19%

Group distribution

RVTY: 0.19%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Largest peers

NVS: 2.88%
ABBV: 2.40%
MRK: 2.29%
JNJ: 1.94%
AZN: 1.73%
LLY: 0.49%
RVTY: 0.19%

Where Revvity (RVTY) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Revvity (RVTY) has payout ratio of 13.40%, above the peer distribution for its industry. The dividend consumes more reported earnings than peers normally do, leaving unusually thin earnings cover.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.40%

Group distribution

RVTY: 13.40%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Largest peers

MRK: 343.43%
ABBV: 117.35%
NVS: 90.46%
JNJ: 80.12%
AZN: 45.38%
LLY: 21.71%
RVTY: 13.40%

Where Revvity (RVTY) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Revvity (RVTY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: RVTY	Industry group median
Dividend Yield (TTM)	0.19%	0.00%
Dividend Payout Ratio (TTM)	13.40%	0.00%

Valuation

P/E Ratio (TTM)

Revvity (RVTY) trades at P/E ratio of 68.94, in the richer earnings-multiple quartile for its industry. That premium needs support from growth, durable earnings, or stronger business quality.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

68.94

Group distribution

Max: 85.34
RVTY: 68.94
Q3: 43.46
Median: 26.69
Q1: 13.30
Min: 0.07

Largest peers

MRK: 148.21
RVTY: 68.94
ABBV: 50.05
LLY: 43.95
JNJ: 41.92
NVS: 31.02
AZN: 26.37

Where Revvity (RVTY) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Revvity (RVTY) trades at 5.88 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.88

Group distribution

Max: 58.18
Q3: 25.77
Median: 7.30
RVTY: 5.88
Q1: 3.01
Min: 0.01

Largest peers

LLY: 13.95
ABBV: 7.80
JNJ: 6.69
RVTY: 5.88
MRK: 5.37
NVS: 5.35
AZN: 4.63

Where Revvity (RVTY) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Revvity (RVTY) trades at 2.39 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.

RVTY

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.39

Group distribution

Max: 13.53
Q3: 6.54
Median: 3.25
RVTY: 2.39
Q1: 1.69
Min: -5.59

Largest peers

LLY: 29.96
NVS: 8.25
JNJ: 8.16
MRK: 8.06
AZN: 5.59
RVTY: 2.39
ABBV: -112.34

Where Revvity (RVTY) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Revvity (RVTY) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
Metric	Current stock: RVTY	Industry group median
P/E Ratio (TTM)	68.94	26.69
P/S Ratio (TTM)	5.88	7.30
P/B Ratio (MRQ)	2.39	3.25
Free Cash Flow Yield (TTM)	3.62%	-1.66%